OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin
Matteo Rossi Sebastiano, Giuseppe Ermondi, Shinji Hadano, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 6, pp. 1652-1660
Closed Access | Times Cited: 23

Showing 23 citing articles:

AlphaFold2 and its applications in the fields of biology and medicine
Zhenyu Yang, Xiaoxi Zeng, Yi Zhao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 218

Drug Design by Pharmacophore and Virtual Screening Approach
Deborah Giordano, Carmen Biancaniello, Maria Antonia Argenio, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 646-646
Open Access | Times Cited: 184

AlphaFold, Artificial Intelligence (AI), and Allostery
Ruth Nussinov, Mingzhen Zhang, Yonglan Liu, et al.
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 34, pp. 6372-6383
Open Access | Times Cited: 102

Computational and bioinformatics tools for understanding disease mechanisms
Mohd Athar, Anu Manhas, Nisarg Rana, et al.
Biocell (2024) Vol. 48, Iss. 6, pp. 935-944
Open Access | Times Cited: 4

Challenges and limitations in computational prediction of protein misfolding in neurodegenerative diseases
Marios G. Krokidis, Georgios Ν. Dimitrakopoulos, Aristidis G. Vrahatis, et al.
Frontiers in Computational Neuroscience (2024) Vol. 17
Open Access | Times Cited: 2

Describing and Sharing Molecular Visualizations Using the MolViewSpec Toolkit
Sebastian Bittrich, Adam Midlik, Mihály Váradi, et al.
Current Protocols (2024) Vol. 4, Iss. 7
Open Access | Times Cited: 2

Preclinical alternative drug discovery programs for monogenic rare diseases. The case of hereditary spastic paraplegias
Matteo Rossi Sebastiano, Shinji Hadano, Fabrizia Cesca, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 10, pp. 104138-104138
Open Access | Times Cited: 2

Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype
Susan M. Hiatt, Slavica Trajkova, Matteo Rossi Sebastiano, et al.
The American Journal of Human Genetics (2022) Vol. 110, Iss. 2, pp. 215-227
Open Access | Times Cited: 11

A comparative study of protein structure prediction tools for challenging targets: Snake venom toxins
Konstantinos Kalogeropoulos, Markus‐Frederik Bohn, David E. Jenkins, et al.
Toxicon (2023) Vol. 238, pp. 107559-107559
Open Access | Times Cited: 6

Protein 3D Graph Structure Learning for Robust Structure-Based Protein Property Prediction
Yufei Huang, Siyuan Li, Lirong Wu, et al.
Proceedings of the AAAI Conference on Artificial Intelligence (2024) Vol. 38, Iss. 11, pp. 12662-12670
Open Access | Times Cited: 1

Restoring adapter protein complex 4 function with small molecules: an in silico approach to spastic paraplegia 50
San Francisco, Lorenzo Lamacchia, Alberto Turco, et al.
Protein Science (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 1

AI ‐Based Protein Structure Predictions and Their Implications in Drug Discovery
Tahsin F. Kellici, Dimitar Hristozov, Iñaki Morao
(2024), pp. 227-253
Closed Access

Artificial intelligence-based protein structure prediction and systems biology-guided smart drug screening
Anshuman Chandra, Nainee Goyal, Ashok Behera, et al.
Elsevier eBooks (2024), pp. 323-352
Closed Access

AI-Driven Drug Discovery for Rare Diseases
Amit Gangwal, Antonio Lavecchia
Journal of Chemical Information and Modeling (2024)
Closed Access

Artificial intelligence-based recognition for variant pathogenicity of BRCA1 using AlphaFold2-predicted structures
Chang Li, Lili Zhang, Zhongling Zhuo, et al.
Theranostics (2022) Vol. 13, Iss. 1, pp. 391-402
Open Access | Times Cited: 3

Predicting the duration of action of β2‐adrenergic receptor agonists: Ligand and structure‐based approaches
Luca Chiesa, Émilie Sick, Esther Kellenberger
Molecular Informatics (2023) Vol. 42, Iss. 12
Open Access | Times Cited: 1

Up-to-Date Developments in Homology Modeling
Muhammed Tılahun Muhammed, Esin Aki
BENTHAM SCIENCE PUBLISHERS eBooks (2023), pp. 116-135
Closed Access | Times Cited: 1

Personalized Treatment for Infantile Ascending Hereditary Spastic Paralysis Based on In Silico Strategies
Matteo Rossi Sebastiano, Giuseppe Ermondi, Kai Sato, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 7063-7063
Open Access | Times Cited: 2

Central nervous system specific high molecular weight ALS2/alsin homophilic complex is enriched in mouse brain synaptosomes
Kai Sato, Kyoko Suzuki-Utsunomiya, Shun Mitsui, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 638, pp. 168-175
Open Access | Times Cited: 1

A Comparative Study of Protein Structure Prediction Tools for Challenging Targets: Snake Venom Toxins
Konstantinos Kalogeropoulos, Markus‐Frederik Bohn, David E. Jenkins, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Deleterious, protein-altering variants in the X-linked transcriptional coregulator ZMYM3 in 22 individuals with a neurodevelopmental delay phenotype
Susan M. Hiatt, Slavica Trajkova, Matteo Rossi Sebastiano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access

Page 1

Scroll to top